Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors

Front Oncol. 2019 May 8:9:365. doi: 10.3389/fonc.2019.00365. eCollection 2019.
No abstract available

Keywords: anti CTLA 4; anti-PD 1; colitis; immune related adverse effects; pneumonitis.

Publication types

  • Editorial